title: Practice-relevant revision of IPSET-thrombosis based on 1019 patients with WHO-defined essential thrombocythemia.
authors.affiliation: Research Foundation, Papa Giovanni XXIII Hospital, Bergamo, Italy.|Division of Hematology, Papa Giovanni XXIII Hospital, Bergamo, Italy.
authors.forename: T
authors.initials: T
authors.lastname: Barbui
authors.affiliation: Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
authors.forename: A M
authors.initials: AM
authors.lastname: Vannucchi
authors.affiliation: Department of Internal Medicine I, Division of Hematology and Blood Coagulation, Medical University of Vienna, Vienna, Austria.
authors.forename: V
authors.initials: V
authors.lastname: Buxhofer-Ausch
authors.affiliation: Institute of Hematology, Catholic University, Rome, Italy.
authors.forename: V
authors.initials: V
authors.lastname: De Stefano
authors.affiliation: Institute of Hematology, Catholic University, Rome, Italy.
authors.forename: S
authors.initials: S
authors.lastname: Betti
authors.affiliation: Division of Hematology, Papa Giovanni XXIII Hospital, Bergamo, Italy.
authors.forename: A
authors.initials: A
authors.lastname: Rambaldi
authors.affiliation: Department of Hematology Oncology, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo, Pavia, Italy.
authors.forename: E
authors.initials: E
authors.lastname: Rumi
authors.affiliation: Division of Hematology, S. Bortolo Hospital, Vicenza, Italy.
authors.forename: M
authors.initials: M
authors.lastname: Ruggeri
authors.affiliation: Division of Hematology, S. Bortolo Hospital, Vicenza, Italy.
authors.forename: F
authors.initials: F
authors.lastname: Rodeghiero
authors.affiliation: Department of Medicine-DIMED, University of Padua, Padua, Italy.
authors.forename: M L
authors.initials: ML
authors.lastname: Randi
authors.affiliation: Department of Medicine-DIMED, University of Padua, Padua, Italy.
authors.forename: I
authors.initials: I
authors.lastname: Bertozzi
authors.affiliation: Department of Internal Medicine I, Division of Hematology and Blood Coagulation, Medical University of Vienna, Vienna, Austria.
authors.forename: H
authors.initials: H
authors.lastname: Gisslinger
authors.affiliation: Division of Hematology, Papa Giovanni XXIII Hospital, Bergamo, Italy.
authors.forename: G
authors.initials: G
authors.lastname: Finazzi
authors.affiliation: Research Foundation, Papa Giovanni XXIII Hospital, Bergamo, Italy.
authors.forename: A
authors.initials: A
authors.lastname: Carobbio
authors.affiliation: Institute for Pathology, University of Cologne, Cologne, Germany.
authors.forename: J
authors.initials: J
authors.lastname: Thiele
authors.affiliation: University Hospital Ospedale di Circolo and Fondazione Macchi, Division of Hematology, Varese, Italy.
authors.forename: F
authors.initials: F
authors.lastname: Passamonti
authors.affiliation: Research Foundation, Papa Giovanni XXIII Hospital, Bergamo, Italy.
authors.forename: C
authors.initials: C
authors.lastname: Falcone
authors.affiliation: Division of Hematology, Mayo Clinic, Rochester, MN, USA.
authors.forename: A
authors.initials: A
authors.lastname: Tefferi
mesh_terms: D001241:Aspirin / Q000627:therapeutic use; D006801:Humans; D053614:Janus Kinase 2 / Q000235:genetics; D009154:Mutation; D012307:Risk Factors; D013920:Thrombocythemia, Essential / Q000150:complications / Q000175:diagnosis* / Q000453:epidemiology / Q000235:genetics; D013927:Thrombosis / Q000145:classification / Q000453:epidemiology / Q000235:genetics; D014944:World Health Organization
chemical_list: C507924:JAK2 protein, human; D053614:Janus Kinase 2; D001241:Aspirin